1. Home
  2. VIR vs MUX Comparison

VIR vs MUX Comparison

Compare VIR & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$9.76

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

N/A

Current Price

$11.83

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
VIR
MUX
Founded
2016
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
VIR
MUX
Price
$9.76
$11.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$23.38
★ $28.40
AVG Volume (30 Days)
★ 1.8M
1.2M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.49
N/A
EPS
N/A
★ 0.10
Revenue
$68,556,000.00
★ $197,553,000.00
Revenue This Year
$305.75
$11.31
Revenue Next Year
N/A
$60.21
P/E Ratio
★ N/A
$120.15
Revenue Growth
N/A
★ N/A
52 Week Low
$5.32
$11.99
52 Week High
$14.38
$29.70

Technical Indicators

Market Signals
Indicator
VIR
MUX
Relative Strength Index (RSI) 39.70 30.82
Support Level $8.23 N/A
Resistance Level $10.32 $20.62
Average True Range (ATR) 0.80 0.85
MACD -0.06 -0.19
Stochastic Oscillator 1.39 4.00

Price Performance

Historical Comparison
VIR
MUX

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

Share on Social Networks: